{{ (moduleVm.actions && moduleVm.changeStatus) ? moduleVm.status : '' }} A Comparison of Preferentially Expressed Antigen in Melanoma Immunohistochemistry and Diagnostic Gene Expression-Profiling Assay in Challenging Melanocytic Proliferations

Activity Steps

1 Activity
2 Take Test 3Certificate

Description

Method of Participation in the Learning Process/Evaluation Method

Successful completion of this activity includes reading the entire article and successfully completing the post-quiz and an evaluation form.

Getting the Most out of the Activity

As you prepare to participate in this activity, please reflect on your practice and your patients and identify clinical challenges you hope to have addressed.

While participating in the training, identify ways you can use newly acquired knowledge, strategies, and skills to enhance patient outcomes and your own professional development.

Learning Objectives

After completing this continuing education activity you will be able to:

  1. Explain performance metrics and practice limitations for diagnostic GEP in comparison with PRAME immunohistochemical stain.
  2. Interpret the results of PRAME immunohistochemistry and identify potential areas for diagnostic discrepancy with the final histologic diagnosis.
  3. Describe available ancillary tools to provide accurate, rapid, and cost-effective results for challenging melanocytic neoplasms.

Disclosures

All authors, faculty, and staff have no relevant financial relationships with any ineligible organizations regarding this educational activity.

Price: $15.00

Credits:

  • ACCME 1.0 CME

Lippincott Continuing Medical Education Institute, Inc. is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Lippincott Continuing Medical Education Institute, Inc. designates this enduring material for a maximum of 1.0 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Planner
Professions: Physician
Test Code: AJD0324
Published: March 2024
Expires: 2/28/2026
Sources: The American Journal of Dermatopathology
Required Passing Score: 4/5 (80%)
Authors: Austin C. Casillas, BS, Aaron Muhlbauer, MD, Victor A. Barragan, BS, Itisha Jefferson, BS, and Jodi J. Speiser, MD
Categories: Dermatology , Pathology
Specialties: Dermatology, Internal Medicine, Pathology
Topics: Melanocytic Neoplasms , Melanoma Immunohistochemistry